A fancd2 antibody, and the targets where validation is the whole difficulty

Some targets have dozens of published clones and few that work. What they have in common is that the signal is low, moves, or sits in a family of near identical proteins, so the control rather than the clone is what makes the result mean something.

An ehmt1 antibody and a chromatin target

An ehmt1 antibody reports a histone methyltransferase that works in a complex with its close relative, so a clone has to be shown not to see the partner, and the nuclear signal is diffuse rather than punctate. A knockdown lysate and a complex member stained in parallel are the controls that make a nuclear stain interpretable.

A rab5a antibody and detecting a trafficking protein

A rab5a antibody reports an early endosome protein that is small, membrane associated and one of a large family, so the signal is punctate and the specificity question is which family member is being seen. Co-staining with a second early endosome marker is the practical check, since the pattern rather than the intensity is the result.

A dc marker panel, and why one marker is never enough

A dc marker is never used alone, because no single antigen defines a dendritic cell: the subsets are resolved by a combination and by excluding the lineages that share individual markers. A panel designed on the subset wanted, with the exclusion channel included, is what makes a rare population readable at all.

immunohistochemistry vs immunofluorescence, and which the target needs

In immunohistochemistry vs immunofluorescence the choice is chromogen against fluorophore: chromogen gives a permanent slide readable on any microscope and a limited dynamic range, while fluorescence gives several targets at once, better co-localisation and a signal that fades. A low abundance or co-localised target needs fluorescence; a routine scored stain does not.

A fully humanized monoclonal antibody and its detection

A fully humanized monoclonal antibody carries human frameworks, which makes it invisible to the anti species secondaries used to detect a mouse clone and is why detecting one in a human sample needs an anti idiotype or a labelled format. The same property is what lowers its immunogenicity as a therapeutic.

Questions people ask about fancd2 antibody

What proves a clone against a family member?

A knockdown lysate plus the relative stained in parallel. A peptide competition proves less.

Chromogen or fluorescence?

Fluorescence for low abundance and co-localisation; chromogen for a routine scored stain on any microscope.

Why is one dendritic cell marker not enough?

No single antigen defines the cell. The subsets need a combination with a lineage exclusion channel.

Sources

Related answers

Get a vendor shortlistCompare synthesis prices